Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro

PLoS One. 2013;8(3):e58129. doi: 10.1371/journal.pone.0058129. Epub 2013 Mar 22.

Abstract

Chemokines and chemokine receptor-mediated effects are important mediators of the immunological response and cure in human leishmaniasis. However, in addition to their signalling properties for leukocytes, many chemokines have also been shown to act directly as antimicrobial peptides on bacteria and fungi. We screened ten human chemokines (CXCL2, CXCL6, CXCL8, CXCL9, CXCL10, CCL2, CCL3, CCL20, CCL27, CCL28) for antimicrobial effects on the promastigote form of the protozoan parasite Leishmania mexicana, and observed direct parasiticidal effects of several, CCL28 being the most potent. Damage to the plasma membrane integrity could be visualised by entrance of propidium iodide, as measured with flow cytometry, and by scanning electron microscopy, which showed morphological changes and aggregation of cells. The findings were in concordance with parasiticidal activity, measured by decreased mitochondrial activity in an MTT-assay. This is the first report of direct antimicrobial activity by chemokines on parasites. This component of immunity against Leishmania parasites identified here warrants further investigation that might lead to new insight in the mechanisms of human infection and/or new therapeutic approaches.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Antiparasitic Agents / pharmacology*
  • Chemokine CCL2 / pharmacology
  • Chemokine CCL20 / pharmacology
  • Chemokine CCL27 / pharmacology
  • Chemokine CCL3 / pharmacology
  • Chemokine CXCL10 / pharmacology
  • Chemokine CXCL2 / pharmacology
  • Chemokine CXCL6 / pharmacology
  • Chemokine CXCL9 / pharmacology
  • Chemokines / pharmacology*
  • Humans
  • Interleukin-8 / pharmacology
  • Leishmania mexicana / drug effects*
  • Peptides / pharmacology*

Substances

  • Anti-Infective Agents
  • Antiparasitic Agents
  • Chemokine CCL2
  • Chemokine CCL20
  • Chemokine CCL27
  • Chemokine CCL3
  • Chemokine CXCL10
  • Chemokine CXCL2
  • Chemokine CXCL6
  • Chemokine CXCL9
  • Chemokines
  • Interleukin-8
  • Peptides

Grants and funding

SS and MC are supported by Swedish governmental funding for clinical research (ALF). MC is supported by grants from the Swedish Research Council (2010-57X-20240), the Foundations of Wiberg, Kock, Bergvall, Österlund, Hedberg, Hedlund, Groschinsky, Söderberg, the Swedish Society for Medicine, the Royal Physiograc Society, King Gustaf Vs Memorial Fund, the Medical Faculty at Lund University, and Hansa Medical AB. The funders had no role in preparation of the manuscript or decision to publish.